close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Biotechnology Pfizer Inc Health & Science
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags stocks Investment Strategy Hims & Hers Health Inc
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Breaking News: Politics US: News Companies
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags JPMorgan Chase & Co World Markets Economic outlook
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Tesla Inc Stock indices and averages Commercial banking
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags ETF Edge stocks Exchange/traded funds
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags US: News Companies Science
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Biotech and Pharmaceuticals Gilead Sciences Inc Cigna Corp
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Biotech and Pharmaceuticals Gilead Sciences Inc Eli Lilly and Co
From CNBC.com News
5 things to know before the stock market opens
Tags Nasdaq Inc Paramount Global Investing
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Novo Nordisk A/S Asia: Top News and Analysis US Top News and Analysis
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Companies Biotech and Pharmaceuticals US: News
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Zealand Pharma A/S Markets Europe News
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Social issues Eli Lilly and Co Health care industry
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Biotechnology CNBC Changemakers Novo Nordisk A/S
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags World Markets World economy Novo Nordisk A/S
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Obesity Health Insurance Employee benefits
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Pharmaceuticals Health care industry Eli Lilly and Co
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags stocks Investment Strategy Palantir Technologies Inc
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Chugai Pharmaceutical Co Ltd stocks ETF Edge
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Internet Teladoc Health Inc Hospitals
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Biotech and Pharmaceuticals Healthy Returns Science
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags World News Europe News AstraZeneca PLC
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Hims & Hers Health Inc Internet Business News
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Health care industry Pharmaceuticals Business
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Health & Science Alphabet Inc Novo Nordisk A/S
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Business News Pharmaceuticals Health care industry
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Eli Lilly and Co Health care industry Health & Science
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Amgen Inc US: News Companies
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Novo Nordisk A/S Health & Science Biotechnology
From CNBC.com News
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.